*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Galunisertib is a potent, selective small-molecule inhibitor of the TGF-β type I receptor (ALK5). Designed for <strong>R&D use only</strong>, it features the molecular formula C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O and CAS No. 1398373-98-2.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Research:</strong> Investigating tumor microenvironment modulation in pancreatic and colorectal cancers.</li>
<li><strong>Fibrosis Studies:</strong> Evaluating therapeutic potential for liver and pulmonary fibrosis models.</li>
<li><strong>Signal Transduction:</strong> Analyzing TGF-β pathway inhibition mechanisms in cellular assays.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for laboratory research; not approved for clinical or diagnostic use. Store at -20°C under inert atmosphere. Handle with appropriate PPE to avoid inhalation or skin contact.</p>